JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M504516200 on June 20, 2005

J. Biol. Chem., Vol. 280, Issue 33, 29912-29920, August 19, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/33/29912    most recent
M504516200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Baserga, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Baserga, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and {beta}-Catenin*

Jia Chen{ddagger}, An Wu{ddagger}, Hongzhi Sun{ddagger}, Robert Drakas{ddagger}, Cecilia Garofalo§, Sandra Cascio§, Eva Surmacz§, and Renato Baserga{ddagger}

From the {ddagger}Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and the §Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania 19122

Previous work has shown that the transcriptional regulator {beta}-catenin can translocate to the nuclei when cells are stimulated with the type 1 insulin-like growth factor (IGF-1). We show by immunocoprecipitation and by confocal microscopy that {beta}-catenin binds to and co-localizes with the insulin receptor substrate-1 (IRS-1), a docking protein for both the insulin and the IGF-1 receptors. IRS-1 is required for IGF-1-mediated nuclear translocation of {beta}-catenin, resulting in the activation of the {beta}-catenin target genes. IGF-1-mediated nuclear translocation of {beta}-catenin is facilitated by the nuclear translocation of IRS-1. Both IRS-1 and {beta}-catenin are recruited to the cyclin D1 promoter, an established target for {beta}-catenin, but only IRS-1 is recruited to the ribosomal DNA (rDNA) promoter. UBF proteins (known to interact with both IRS-1 and {beta}-catenin) are also detectable in the cyclin D1 and rDNA promoters. These results indicate that IRS-1 (activated by the IGF-1 receptor) is one of several proteins that regulate the subcellular localization and activity of {beta}-catenin. The ability of IRS-1 to localize to both RNA polymerase II (with {beta}-catenin) and RNA polymerase I-regulated promoters suggest an explanation for the effect of IRS-1 on both cell growth in size and cell proliferation. This possibility is supported by the demonstration that enforced nuclear localization of IRS-1 causes nuclear translocation of {beta}-catenin and transformation of normal mouse embryo fibroblasts (colony formation in soft agar).


Received for publication, April 25, 2005 , and in revised form, June 9, 2005.

* This work was supported by Grants CA089640 and AG20956 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Kimmel Cancer Center, Thomas Jefferson University, 233 S. 10th St., 624 Bluemle Life Sciences Bldg., Philadelphia, PA 19107. Tel.: 215-503-4507; Fax: 215-923-0249; E-mail: B_lupo{at}mail.jci.tju.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
S. R. Parathath, L. A. Mainwaring, A. Fernandez-L, D. O. Campbell, and A. M. Kenney
Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors
Development, October 1, 2008; 135(19): 3291 - 3300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
M. Shimizu, Y. Shirakami, H. Sakai, S. Adachi, K. Hata, Y. Hirose, H. Tsurumi, T. Tanaka, and H. Moriwaki
(-)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice
Cancer Prevention Research, September 1, 2008; 1(4): 298 - 304.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Giustina, G. Mazziotti, and E. Canalis
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Endocr. Rev., August 1, 2008; 29(5): 535 - 559.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. E. Dube, K. J. Rowland, and P. L. Brubaker
Glucagon-Like Peptide-2 Activates -Catenin Signaling in the Mouse Intestinal Crypt: Role of Insulin-Like Growth Factor-I
Endocrinology, January 1, 2008; 149(1): 291 - 301.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. M. Ramocki, H. R. Wilkins, S. T. Magness, J. G. Simmons, B. P. Scull, G. H. Lee, K. K. McNaughton, and P. K. Lund
Insulin Receptor Substrate-1 Deficiency Promotes Apoptosis in the Putative Intestinal Crypt Stem Cell Region, Limits Apcmin/+ Tumors, and Regulates Sox9
Endocrinology, January 1, 2008; 149(1): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
D. Sisci, C. Morelli, C. Garofalo, F. Romeo, L. Morabito, F. Casaburi, E. Middea, S. Cascio, E. Brunelli, S. Ando, et al.
Expression of nuclear insulin receptor substrate 1 in breast cancer
J. Clin. Pathol., June 1, 2007; 60(6): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga
Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells
Cancer Res., March 1, 2007; 67(5): 2124 - 2130.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. K. Dearth, X. Cui, H.-J. Kim, I. Kuiatse, N. A. Lawrence, X. Zhang, J. Divisova, O. L. Britton, S. Mohsin, D. C. Allred, et al.
Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2
Mol. Cell. Biol., December 15, 2006; 26(24): 9302 - 9314.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
V. Rider, K. Isuzugawa, M. Twarog, S. Jones, B. Cameron, K. Imakawa, and J. Fang
Progesterone initiates Wnt-{beta}-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells
J. Endocrinol., December 1, 2006; 191(3): 537 - 548.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Natrajan, J. S. Reis-Filho, S. E. Little, B. Messahel, M.-A. Brundler, J. S. Dome, P. E. Grundy, G. M. Vujanic, K. Pritchard-Jones, and C. Jones
Blastemal Expression of Type I Insulin-Like Growth Factor Receptor in Wilms' Tumors Is Driven by Increased Copy Number and Correlates with Relapse
Cancer Res., December 1, 2006; 66(23): 11148 - 11155.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K. Willert and K. A. Jones
Wnt signaling: is the party in the nucleus?
Genes & Dev., June 1, 2006; 20(11): 1394 - 1404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.